{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:36:29Z","timestamp":1790976989883,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,2]],"date-time":"2027-10-02T00:00:00Z","timestamp":1822435200000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtho.2026.104061","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:57:01Z","timestamp":1782345421000},"page":"104061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brief Report: Proposed Clinical Trial Guidelines Based on Clinicopathologic Heterogeneity of Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Noura J.","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Gezelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Arfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Baine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Falcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5204-3465","authenticated-orcid":false,"given":"Charles M.","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2026.104061_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104061_bib2","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2026.104061_bib3","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104061_bib4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2026.104061_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104061_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.lungcan.2015.09.002","article-title":"Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor","volume":"90","author":"Kogo","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104061_bib7","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2169\/internalmedicine.56.7452","article-title":"Histological transformation to large cell neuroendocrine carcinoma from lung adenocarcinoma harboring an EGFR mutation: an autopsy case report","volume":"56","author":"Moriya","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jtho.2026.104061_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2020.100028","article-title":"Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface","volume":"6","author":"Belluomini","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.jtho.2026.104061_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.athoracsur.2011.05.027","article-title":"Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience","volume":"92","author":"Sarkaria","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.104061_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jtho.2026.104061_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107454","article-title":"Real-world comprehensive genomic profiling data for diagnostic clarity in pulmonary large-cell neuroendocrine carcinoma","volume":"188","author":"Burns","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104061_bib12","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jtho.2026.104061_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108830","article-title":"Treatment outcomes in patients with stage IV large cell neuroendocrine carcinoma: a nationwide registry study","volume":"210","author":"Heijboer","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104061_bib14","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1038\/s41467-025-63091-0","article-title":"Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma","volume":"16","author":"Nassar","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2026.104061_bib15","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO-25-00363","article-title":"Phase I dose-escalation results for the delta-like ligand 3\/CD3 IgG-like T-Cell engager obrixtamig (BI 764532) in patients with delta-like ligand 3+ small cell lung cancer or neuroendocrine carcinomas","volume":"43","author":"Wermke","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104061_bib16","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1158\/1078-0432.CCR-25-2090","article-title":"Seizure-related homolog protein 6 (SEZ6): biology and therapeutic target in neuroendocrine carcinomas","volume":"31","author":"Gezelius","year":"2025","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426005149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426005149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:40:54Z","timestamp":1790934054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086426005149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1556086426005149"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104061","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brief Report: Proposed Clinical Trial Guidelines Based on Clinicopathologic Heterogeneity of Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104061"}}